Momenta, Sandoz Can't Beat Blood Clot Drug Monopoly Suit

A Tennessee federal magistrate judge on Thursday recommended that a proposed class action accusing Momenta Pharmaceuticals Inc. and Sandoz Inc. of conspiring to monopolize the market for a generic of the...

Already a subscriber? Click here to view full article